March 9, 2023
Tag: Multiple Myeloma and Amyloidosis Clinical Program
December 15, 2022
Studies identify barriers between doctors and their patients that limit clinical trial enrollment for Black people with blood cancers
Shakira Grant, MBBS, the studies’ principal investigator, shared the findings during oral presentations at the annual meeting of the American Society of Hematology (ASH) in New Orleans.
December 15, 2022
Study identifies health care access barriers for older adults with multiple myeloma and their caregivers
A study led by UNC Lineberger's Shakira Grant, MBBS, and colleagues found several barriers to high-quality cancer care for people with multiple myeloma and their caregivers.
November 10, 2022
Cancer Network: Evaluating MRD-Guided Therapy in Patients with NDMM
June 26, 2022
Hematologist focuses on multiple myeloma, amyloidosis
Sascha Tuchman, MD, MHS, specializes in hematology, and specifically multiple myeloma and amyloidosis. At UNC Lineberger, he collaborates with other UNC Lineberger clinicians and scientists, and works to cultivate the next generation of myeloma experts.
November 22, 2021
Grant receives $200,000 NIH grant to study impact of multiple myeloma on older adults, care partners
UNC Lineberger’s Shakira Grant, MBBS, was awarded a two-year research grant to study the illness and treatment experiences of older adults with multiple myeloma and their care partners.
May 2, 2021
CBS17: Durham boy celebrates birthday, honors grandfather’s memory with donation to UNC Cancer Center
May 20, 2020
WRAL: Durham boy donates birthday money to cancer research
October 21, 2019
Myeloma Research News: Multiple Myeloma Patients Best Treated at Recognized Care Centers with High Volume, US Study Reports
October 29, 2018
Former patient donates $10 million to further blood cancer research at UNC Lineberger
Etteinne “ET” and W. G. Champion “Champ” Mitchell of New Bern, North Carolina, will create a new fund supporting ground-breaking research in blood cancer at UNC Lineberger Comprehensive Cancer Center, including lymphoma, leukemia and myeloma research, in gratitude for the care Champ received and to bolster research directed at finding cures.